Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Novel Treatment Approaches for the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer (Faculty Presentations)
Virginia Kaklamani
MD, DSc
UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas
Professor of Medicine, Ruth McLean Bowman Bowers Chair in Breast Cancer Research and Treatment, AB Alexander Distinguished Chair in Oncology, Leader, Breast Oncology Program
Hope S Rugo
MD
City of Hope Comprehensive Cancer Center, Duarte, California
Director, Women’s Cancers Program, Division Chief, Breast Medical Oncology, Professor, Department of Medical Oncology and Therapeutics Research
University of California, San Francisco
Professor Emeritus